Skip to Content

Hartford Balanced Income C HBLCX

Medalist Rating as of | See Hartford Funds Investment Hub
  • NAV / 1-Day Return 14.45  /  +0.63 %
  • Total Assets 12.4 Bil
  • Adj. Expense Ratio
    1.630%
  • Expense Ratio 1.630%
  • Distribution Fee Level Average
  • Share Class Type Level Load
  • Category Moderately Conservative Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity Medium/Moderate
  • Status Open
  • TTM Yield 2.77%
  • Turnover 57%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0

Morningstar’s Analysis HBLCX

Will HBLCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A compelling offering.

Associate Analyst Nour Al Twal

Nour Al Twal

Associate Analyst

Summary

The portfolio managers running Hartford Balanced Income are skilled and well-resourced. This income strategy combines two complementary sleeves in a disciplined manner, giving it an edge over its category peers. However, the fees of the more-expensive share classes can overwhelm the combined strengths of the team and approach.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HBLCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 9.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

JPMorgan Chase & Co

1.56 190.5 Mil
Financial Services

Pfizer Inc

1.38 167.8 Mil
Healthcare

UnitedHealth Group Inc

1.27 154.4 Mil
Healthcare

Johnson & Johnson

1.17 142.1 Mil
Healthcare

Usd

1.08 131.2 Mil
Cash and Equivalents

2 Year Treasury Note Future Sept 24

1.06 129.1 Mil
Government

EOG Resources Inc

1.01 123.4 Mil
Energy

ConocoPhillips

0.96 116.5 Mil
Energy

Cisco Systems Inc

0.95 115.7 Mil
Technology

Merck & Co Inc

0.92 112.5 Mil
Healthcare